mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
Irinotecan |
FIMM |
pan-cancer |
AAC |
0.041 |
0.7 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.7 |